Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Maura

Showing results (71-80 of 146) with videos related to

Pageof 15
Sort By:
Blood Advances|March 4, 2020
Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myelomaBachisio Ziccheddu, Giulia Biancon, Filippo Bagnoli, et al.
Blood Cancer Journal|January 11, 2023
Extreme body mass index and survival in newly diagnosed multiple myeloma patientsUrvi A Shah, Karissa Whiting, Sean Devlin, et al.
Plos One|September 8, 2011
Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemiaFrancesco Maura, Giovanna Cutrona, Sonia Fabris, et al.
American Journal of Hematology|November 2, 2012
B-cell receptor configuration and adverse cytogenetics are associated with autoimmune hemolytic anemia in chronic lymphocytic leukemiaFrancesco Maura, Carlo Visco, Erika Falisi, et al.
Blood Cancer Journal|February 1, 2020
Correction: Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myelomaVenkata Yellapantula, Malin Hultcrantz, Even H Rustad, et al.
British Journal of Haematology|March 4, 2014
High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implicationsMarta Lionetti, Sonia Fabris, Giovanna Cutrona, et al.
Blood Cancer Journal|December 13, 2019
Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myelomaVenkata Yellapantula, Malin Hultcrantz, Even H Rustad, et al.
Hemasphere|April 20, 2026
Whole-genome sequencing of cell-free DNA for assessment of minimal residual disease in high-risk smoldering multiple myelomaChrissy Baker, Elizabeth Hill, Dickran Kazandjian, et al.
Blood|September 25, 2025
Genomic landscape of IgM-MGUS and patients with stable or progressive asymptomatic Waldenström macroglobulinemiaTina Bagratuni, Ourania Theologi, Christos Vlachos, et al.
Cancer Research|July 31, 2025
Blocking NRF2 Translation by Inhibition of Cap-Dependent Initiation Sensitizes Lymphoma Cells to Ferroptosis and CAR T-cell ImmunotherapyPaola Manara, Austin D Newsam, Venu Venkatarame Gowda Saralamma, et al.
Pageof 15

Showing results (71-80 of 146) with videos related to

Sort By:
Pageof 15
Blood Advances|March 4, 2020
Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myelomaBachisio Ziccheddu, Giulia Biancon, Filippo Bagnoli, et al.
Blood Cancer Journal|January 11, 2023
Extreme body mass index and survival in newly diagnosed multiple myeloma patientsUrvi A Shah, Karissa Whiting, Sean Devlin, et al.
Plos One|September 8, 2011
Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemiaFrancesco Maura, Giovanna Cutrona, Sonia Fabris, et al.
American Journal of Hematology|November 2, 2012
B-cell receptor configuration and adverse cytogenetics are associated with autoimmune hemolytic anemia in chronic lymphocytic leukemiaFrancesco Maura, Carlo Visco, Erika Falisi, et al.
Blood Cancer Journal|February 1, 2020
Correction: Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myelomaVenkata Yellapantula, Malin Hultcrantz, Even H Rustad, et al.
British Journal of Haematology|March 4, 2014
High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implicationsMarta Lionetti, Sonia Fabris, Giovanna Cutrona, et al.
Blood Cancer Journal|December 13, 2019
Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myelomaVenkata Yellapantula, Malin Hultcrantz, Even H Rustad, et al.
Hemasphere|April 20, 2026
Whole-genome sequencing of cell-free DNA for assessment of minimal residual disease in high-risk smoldering multiple myelomaChrissy Baker, Elizabeth Hill, Dickran Kazandjian, et al.
Blood|September 25, 2025
Genomic landscape of IgM-MGUS and patients with stable or progressive asymptomatic Waldenström macroglobulinemiaTina Bagratuni, Ourania Theologi, Christos Vlachos, et al.
Cancer Research|July 31, 2025
Blocking NRF2 Translation by Inhibition of Cap-Dependent Initiation Sensitizes Lymphoma Cells to Ferroptosis and CAR T-cell ImmunotherapyPaola Manara, Austin D Newsam, Venu Venkatarame Gowda Saralamma, et al.
Pageof 15